Oakland University
Also known as: Beaumont Health | Beaumont Health - Farmington Hills | Beaumont Health System | Beaumont Health System, Royal Oak | Beaumont Hospital-Royal Oak | Beaumont Hospital, Royal Oak MI | Beaumont Hospitals | Beaumont Physician Partners | Director of Internal Medicine Research | Oakland Medical Research Center, Troy, MI | Oakland Medical Research Center, Troy, MI 48085 | Oakland University | Oakland University, William Beaumont School of Medicine | Prof., Dept. of Emergency Medicine, Oakland University, William Beaumont School of Medicine, Royal Oak, MI | Professor & Chair, Department of Urology, Oakland University Wm. Beaumont School of Medicine | William Beaumont Hospital and Oakland University School of Medicine | William Beaumont Hospital - Farmington Hills | William Beaumont Hospital Hospital | William Beaumont Hospitals
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2006Last known activity
Nov 1, 2025
Timeline
1950s
- Jan 1, 1957
Oakland University— Founded
Drugs by trial phase (57 distinct, 36 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (28 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Appendicitis
- Bacteremia
- Bone Demineralization, Pathologic
- Catheter-Related Infections
- Central Nervous System Neoplasms
- Chronic Disease
- Clostridium Infections
- Colorectal Neoplasms
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Cystitis
- Cystitis, Interstitial
- Dacryocystitis
- Diabetes Mellitus, Type 2
- Enuresis
- Fatty Liver
- Fibrosis
- Glioblastoma
- Heart Arrest
- Heart Diseases
- Heart Valve Diseases
- Hypertension
- Infections
- Influenza, Human
- Ischemia
- Lacerations
- Lacrimal Apparatus Diseases
- Liver Cirrhosis
- Liver Diseases
- Lower Urinary Tract Symptoms
- Myocardial Ischemia
- Nervous System Neoplasms
- Non-alcoholic Fatty Liver Disease
- Pelvic Pain
- Postoperative Pain
- Prostatitis
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Severe Acute Respiratory Syndrome
- Syndrome
- Urinary Bladder Neoplasms
- Urinary Bladder, Overactive
- Urinary Bladder, Underactive
- Urinary Incontinence
- Urinary Incontinence, Stress
- Urinary Retention
- Urinary Tract Infections
- Urination Disorders
- Urological Manifestations
- Urologic Diseases
- Vulvodynia
Recent trials (50)
- NCT07202000CollaboratorPhase 2Nov 1, 2025
- NCT06745388Sponsor investigatorPhase 4Feb 28, 2025
- NCT06745388OfficialPhase 4Feb 28, 2025
- NCT06745388Lead sponsorPhase 4Feb 28, 2025
- NCT05568537Lead sponsorPhase 4Nov 30, 2022
- NCT05568537Overall official - principal investigatorPhase 4Nov 30, 2022
- NCT05568537Sponsor investigatorPhase 4Nov 30, 2022
- NCT05418777Overall official - principal investigatorPhase 1/Phase 2Sep 28, 2022
- NCT05418777Reponsible party - principal investigatorPhase 1/Phase 2Sep 28, 2022
- NCT05418777Lead sponsorPhase 1/Phase 2Sep 28, 2022
- NCT04432272Overall official - principal investigatorPhase 2Jun 30, 2020
- NCT04432272Lead sponsorPhase 2Jun 30, 2020
- NCT04432272Reponsible party - principal investigatorPhase 2Jun 30, 2020
- NCT04365985Reponsible party - principal investigatorPhase 2Apr 29, 2020
- NCT04365985Overall official - principal investigatorPhase 2Apr 29, 2020
Details
- Founded
- Rochester, MI, US Jan 1, 1957
- Last known activity
- Nov 1, 2025